star icon Benefits menu iconDashboard
See Price & Plans

Not registered yet? Get a free account.

Sign Up
search icon cancel icon
Parenteral Drugs (India) Limited Location T. Score Peers
Financials
Charges People Network Registered Details

PARENTERAL DRUGS (INDIA) LIMITED

parenteral-drugs-india-limited.business.site

Leave site?

You're about to leave our website and go to an external link. Are you sure?

Active
Updated: 21 Oct 2024

Parenteral Drugs (India) Limited, is an unlisted public company incorporated on 13 December, 1983. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 50.00 cr and the total paid-up capital is INR 29.82 cr.

Parenteral Drugs (India) Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2021.

Read more

coin img Buy Dashboard using Credits

cancel img

Just a Quick Check!

This action will use 1 of your credits. Are you sure you want to go ahead?

coins img Credits Balance: 0
Checkout other plans arrow img

Industry

Manufacturing (Chemicals and chemical products)
Products
  • pharma or chemist., medical equipments, other things related to medicines, herbal medicines, medicines, All drugs
Key Metrics

** All rupee values in INR crores. Based on March 2021 numbers.

Sales
-61.83%
₹ GET PRO
EBITDA
-
₹ GET PRO
Net Profit
-
₹ GET PRO
Networth
-
₹ GET PRO
Borrowings
-
₹ GET PRO
Assets
2.97%
₹ GET PRO
Gross Margin
-26.72
GET PRO%
Operating Margin
-50.68
GET PRO%
Net Profit Margin
-640.02
GET PRO%
Return on Equity
-
GET PRO%
ROCE
-1.48
GET PRO%
Debt to Equity
0.03
GET PRO
Sales
Mar 2021
Net worth
Mar 2021

filter-square Buy Report or Plans

filter-square

Dashboards

Popular Plan
  • crown icon Company dashboard
    ₹ 449
    • green tick img Five year financials and ratios
    • green tick img Risk analysis
    • green tick img Interactive charts
View subscriptions and buy credits arrow icon

MCA Fillings

  • All financials
    ₹ 349
    • green tick img All financials
    • green tick img All annual returns
    • green tick img MoA and AoA
  • 1 Year
    ₹ 249
    • green tick img Latest financials
    • green tick img Latest annual return
    • green tick img MoA and AoA

PDF Reports

  • Financial report
    ₹ 799
    • green tick img Five year financials and ratios
    • green tick img Shareholding and group structure
    • green tick img Litigation and more
  • Due diligence report
    ₹ 2999
    • green tick img Everything in financial report
    • green tick img Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

indian flag India (1)
State Type Address

location icon Locations on Map

Map placeholder

filter-square Filter (4)

filter-square

Select Tags

Choose Location

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Peers / Similar Companies

Riocare India Private Limited Maharashtra
Suraksha Pharma Private Limited Telangana
Suncare Formulations Private Limited Uttarakhand

Peers

Financial Highlights

** All numbers in INR crores
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

₹
%
** All numbers in INR crores
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Profit & Loss

₹
%
** All numbers in INR crores
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Sales + GET PRO GET PRO GET PRO GET PRO GET PRO
Sales growth % GET PRO GET PRO GET PRO GET PRO GET PRO
Expenses + GET PRO GET PRO GET PRO GET PRO GET PRO
Cost of goods GET PRO GET PRO GET PRO GET PRO GET PRO
Employee cost GET PRO GET PRO GET PRO GET PRO GET PRO
Other costs GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit + GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin % GET PRO GET PRO GET PRO GET PRO GET PRO
Other income GET PRO GET PRO GET PRO GET PRO GET PRO
Interest GET PRO GET PRO GET PRO GET PRO GET PRO
Depreciation GET PRO GET PRO GET PRO GET PRO GET PRO
Exceptional items GET PRO GET PRO GET PRO GET PRO GET PRO
Profit before tax GET PRO GET PRO GET PRO GET PRO GET PRO
Tax GET PRO GET PRO GET PRO GET PRO GET PRO
Profit - disc. ops GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin % GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Revenue from operations

Ratios

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Solvency +
Total Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Net Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Total Debt/Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total Assets/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Liquidity +
Current Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Quick Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Interest Coverage GET PRO GET PRO GET PRO GET PRO GET PRO
Performance
Gross Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Return +
Return on Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROCE GET PRO GET PRO GET PRO GET PRO GET PRO
Return on Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROIC GET PRO GET PRO GET PRO GET PRO GET PRO
Efficiency +
Days Payable GET PRO GET PRO GET PRO GET PRO GET PRO
Days Inventory GET PRO GET PRO GET PRO GET PRO GET PRO
Days Receivable GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Total Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital
Cash Conversion Cycle GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital Days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Ratios

Current ratio
Debt/equity ratio

Charges on assets

Bank wise
Charges
1

NATIONAL ASSET RECONSTRUCTION COMPANY LIMITED

No. of Loans: 8

Total Amount : 547.5 cr

chart icon

Charges

NATIONAL ASSET RECONSTRUCTION COMPANY LIMITED

People

Designation Name DIN/PAN Tenure
CFO Vinod Kumar Gupta <HIDDEN> 6 years
Director Manohar Lal Gupta 00040784 41 years
Director Dilip Kumar Sinha
Shareholder
00366192 19 years

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
PDPL HOLDINGS PRIVATE LIMITED
Active
85.8 L 1 Maharashtra
PDPL SECURITIES PRIVATE LIMITED
Active
16.0 L 1 Maharashtra
M V G MERCANTILE PRIVATE LIMITED
Active
1.0 L 1 Maharashtra
ABHAY DRUGS LIMITED
Strike Off
5.0 L 1 Maharashtra
PARENTERAL IMPEX LIMITED
Active
5.0 L 1 Maharashtra
ANJANEY PHARMACEUTICALS LIMITED
Strike Off
5.0 L 1 Maharashtra
PFL HOLDINGS PRIVATE LIMITED
Amalgamated
1.0 L 1 Maharashtra
GOA HOLDINGS (INDIA) PRIVATE LIMITED
Amalgamated
1.0 L 1 Maharashtra
PUNJAB FORMULATIONS LIMITED
Amalgamated
7.8 Cr 1 Maharashtra
PARENTERAL BIOTECH LIMITED
Active
25.0 L 1 Maharashtra
INFUTEC HEALTHCARE (INDIA) LIMITED
Active
5.0 L 1 Maharashtra
INFUTEC HEALTHCARE LIMITED
Active
57.7 Cr 1 Maharashtra
SRIVASTAVAS GREEN HOUSE PVT LTD
Strike Off
1.1 Cr 1 Maharashtra

Subsidiary Companies

Name State / Country Incorporation Year Paidup Capital
PARENTERAL BIOTECH LIMITED Maharashtra 1995 ₹ 25.0 L
PARENTERAL IMPEX LIMITED Maharashtra 2006 ₹ 5.0 L
INFUTEC HEALTHCARE LIMITED Maharashtra 2005 ₹ 57.7 Cr

Registered Details

CIN

L24100MH1983PLC126481

PAN

AAACP2820L

Incorporation

1983, 41.0 years

Company Email

cs.pdpl@pdindia.com

Paid up Capital

₹ 29.8 Cr

Authorised Capital

₹ 50.0 Cr

AGM

Sep 2021

Type

Public
Non-government Company

Last Balance Sheet Date

Mar 2021 Updated on : 21 Oct 2024
* This is the date provided by MCA, but availability for this year is not guaranteed.

FAQ - PARENTERAL DRUGS (INDIA) LIMITED

What is the incorporation date of PARENTERAL DRUGS (INDIA) LIMITED?

plus icon

The incorporation date of PARENTERAL DRUGS (INDIA) LIMITED is 13 December, 1983

What is the authorized share capital of PARENTERAL DRUGS (INDIA) LIMITED?

plus icon

The authorized share capital of PARENTERAL DRUGS (INDIA) LIMITED is INR ₹ 50.0 Cr.

What is the paid-up capital of PARENTERAL DRUGS (INDIA) LIMITED?

plus icon

The paid-up capital of PARENTERAL DRUGS (INDIA) LIMITED is INR ₹ 29.8 Cr.

What is the registered address of PARENTERAL DRUGS (INDIA) LIMITED?

plus icon

The registered address of PARENTERAL DRUGS (INDIA) LIMITED is E/210, 2nd Floor, Crystal Plaza, Off New Link Road Andheri West Mumbai Mumbai City Maharashtra - 400053

What is the CIN number of PARENTERAL DRUGS (INDIA) LIMITED?

plus icon

The CIN number of PARENTERAL DRUGS (INDIA) LIMITED is L24100MH1983PLC126481.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More